You've Probably Already Tried Adaptogens. You Probably Felt Nothing.
If you've bought an ashwagandha supplement and not noticed much difference. If you've tried a lion's mane product and still felt foggy. If you've been through multiple adaptogen blends without a clear result — you're not imagining it. You're not unusually resistant to these compounds. The products almost certainly didn't contain enough of the active ingredient to produce any measurable physiological effect.
This is the central, open secret of the UK adaptogen industry: the vast majority of products on the market are dosed so far below what clinical research uses that they cannot work. Not "might not work." Cannot. The pharmacology is clear. The dose-response is real. And the gap between what studies use and what products contain is enormous.
Here's the evidence.
What Clinical Research Actually Uses
Every adaptogen benefit you've read about — reduced cortisol, improved focus, better sleep, stress resilience — comes from peer-reviewed studies. Those studies use specific doses of specific extracts. Not "some ashwagandha." Specific, standardised extracts at specific milligram amounts, taken daily for specific durations.
Ashwagandha: What the Research Uses
The landmark studies on ashwagandha use KSM-66 — a full-spectrum root extract standardised to minimum 5% withanolides. The doses in studies showing measurable results:
- 300mg KSM-66 twice daily (600mg total) — Chandrasekhar et al. (2012): 27.9% reduction in serum cortisol, significant reductions in perceived stress scale scores over 60 days.
- 300mg KSM-66 daily — Choudhary et al. (2017): significant improvements in memory, cognitive functions, and sleep quality.
- 240mg Sensoril daily — Pratte et al. (2014): significant reductions in stress, anxiety, and cortisol.
Now look at a typical UK ashwagandha supplement. Many contain 100–200mg of generic ashwagandha root powder — not KSM-66, not standardised to any withanolide content. That's not 50% of the research dose. That's a fraction of the research dose delivered in a form that doesn't match what was studied. The chances of replicating those clinical outcomes are essentially zero.
Lion's Mane: What the Research Uses
The clinical trials showing cognitive benefits from lion's mane use:
- 3g/day of dried fruiting body — Mori et al. (2009): significant improvement in cognitive function scale scores versus placebo in adults with mild cognitive impairment over 16 weeks.
- 500mg–1g of fruiting body extract daily — the minimum doses showing NGF stimulation in human studies.
- Dual-extracted fruiting body — both water-extracted beta-glucans and alcohol-extracted hericenones/erinacines are required for full activity.
Walk through any health food shop or UK supplement website. You'll find lion's mane products containing 50mg, 80mg, sometimes 100mg — of mycelium, not fruiting body, often extracted with water only, missing the hericenones entirely. A product with 50mg of mycelium-on-grain powder is not delivering 10% of the clinical dose. It's delivering something closer to 1–2% of a meaningful amount of actual active compounds. You will feel nothing. This is not a failure of adaptogens. It's a failure of product formulation.
Rhodiola Rosea: What the Research Uses
Studies showing reductions in mental fatigue, burnout, and cognitive performance under stress use:
- 200–400mg/day of extract standardised to 3% rosavins and 1% salidroside — the natural ratio found in wild rhodiola root, and what's used in trials by Shevtsov et al. (2003) and Spasov et al. (2000) showing significant acute fatigue reduction.
- 576mg/day — Olsson et al. (2009): significant reductions in burnout symptoms and improved attention over 12 weeks.
Generic "rhodiola extract" without stated standardisation tells you nothing. Rhodiola products standardised to rosavins only (without salidroside) are not using the natural compound ratio. Doses under 200mg are below the range of any positive human trial. Many UK products contain exactly these problems.
Reishi: What the Research Uses
Meaningful reishi studies use 1–5g per day of standardised extract, dual-extracted to capture both water-soluble polysaccharides and alcohol-soluble triterpenes. The majority of "reishi capsules" in the UK contain 200–500mg of mycelium powder. That's neither the right part of the mushroom, nor the right extraction, nor the right dose.
The Industry Economics Behind Underdosing
This isn't an accident. It's a rational economic decision made by brands optimising for margin rather than efficacy.
KSM-66 ashwagandha at 600mg per serving costs significantly more per unit than generic ashwagandha root powder at 200mg. Dual-extracted lion's mane fruiting body at 1g per serving costs more than mycelium-on-grain powder at 50mg. When your business model is to sell supplements at a price point that competes with Amazon's cheapest options, ingredient quality and dose are the first things to cut.
The result is an industry where:
- Most products include real adaptogenic ingredients — but at doses that cannot produce the effects those ingredients are known for
- Label claims are technically accurate (it does contain lion's mane) but practically misleading (not at a dose that does anything)
- Consumers try adaptogens, feel nothing, conclude "they don't work for me," and move on
- The brands that actually formulate at clinical doses get drowned out by cheaper competitors with better marketing
This is why "do adaptogens work?" is even a question. They work — when dosed properly. The studies are unambiguous. The problem is almost entirely in the products, not the ingredients.
How to Calculate If Your Current Supplement Is Dosed Effectively
Use this as a quick checklist:
Step 1: Identify the extract type
Does the label say "KSM-66 ashwagandha" or "Sensoril" — or just "ashwagandha extract" or "ashwagandha root powder"? The named patented extract has a specific production process, standardised withanolide content, and the clinical trial evidence. A generic label does not.
Step 2: Check the milligrams against clinical research
Compare what's on the label to the doses in human studies:
- Ashwagandha: need 300–600mg KSM-66 or equivalent standardised extract
- Lion's mane: need 500mg–1g fruiting body dual-extract minimum
- Rhodiola: need 200–400mg standardised to 3% rosavins + 1% salidroside
- Reishi: need 1g+ dual-extracted standardised extract
- Bacopa: need 300mg standardised to 45% bacosides
Step 3: Check for "proprietary blends"
A "proprietary adaptogen blend 500mg" containing lion's mane, ashwagandha, rhodiola, reishi, and bacopa means each ingredient has roughly 100mg or less — below clinical threshold for every single one. Proprietary blends exist to hide individual doses. If a brand won't tell you how much of each ingredient you're getting, assume it's not enough.
Step 4: Confirm the extraction method for mushrooms
"Lion's mane extract" means nothing without knowing: fruiting body or mycelium? Water-extracted only, or dual-extracted (water + alcohol)? Beta-glucan content stated? A hot-water-only extract of lion's mane mycelium does not contain meaningful hericenones. You need dual-extracted fruiting body to get both the beta-glucans and the hericenones that the research attributes benefits to.
Why Getting the Dose Right Is Also the Better Value
A common response to this is: "but quality supplements are expensive." Here's the reframe. An underdosed product at £20/month that produces no effect is infinitely more expensive than an effective product at £40/month that delivers what's advertised. You're not comparing £20 to £40. You're comparing £0 of value to £40 of value. Paying for something that doesn't work is not saving money.
There's also a direct cost comparison. To get 600mg of KSM-66 ashwagandha equivalent from a product containing 200mg of generic ashwagandha root powder, you'd need to take three servings — tripling your cost. A properly dosed product at a higher price point can easily be better value per effective dose. Run the maths on your current supplements.
What a Properly Dosed Adaptogen Product Looks Like
A supplement you can actually expect to feel benefits from will have:
- Named patented extracts — KSM-66, Sensoril, or equivalent with stated standardisation
- Individual ingredient doses that match clinical research — not blended into a proprietary blend
- Fruiting body mushroom extracts, dual-extracted — with stated beta-glucan percentage
- Transparent labelling — every ingredient, every dose, no hidden amounts
- Third-party certificates of analysis — confirming what's on the label is actually in the product
These products cost more to make. They will cost more to buy. That relationship is not a coincidence.
Bottom Line
Adaptogens work. The clinical evidence is strong, consistent, and growing. But "adaptogens work" refers to specific compounds at specific doses — not to any product that includes the word "ashwagandha" on the label. Most UK supplement products are dosed so far below clinical thresholds that they are pharmacologically inert. If you've tried adaptogens and felt nothing, the overwhelming probability is that the product was the problem, not you. The solution is to find a product that actually doses to the science — and to demand that transparency before you buy. See our dosing-specific guides for each ingredient: ashwagandha, lion's mane, rhodiola, and reishi.
